February 2007
Effective: January 1, 2007
In the January 2007 Newsline, we published notification of a revision to this LCD to reflect the Annual CPT/HCPCS Update for 2007 which removed J7317, J7320 and J3590 and added J7319 (Hyaluronan (Sodium Hyaluronate) or derivative, intra-articular injection, per injection). CMS reversed the decision to fold all sodium hyaluronate reimbursement codes into one code, and published new Q codes for each sodium hyaluronate product. For 2007, Medicare will recognize the following Q codes for purposes of billing sodium hyaluronate injections.
| Q4083 - | Hyaluronan or derivative, Hyalgan or Supartz, for intra-articular injection, per dose |
| Q4084 - | Hyaluronan or derivative, Synvisc, for intra-articular injection, per dose |
| Q4085 - | Hyaluronan or derivative, Euflexxa, for intra-articular injection, per dose |
| Q4086 - | Hyaluronan or derivative, Orthovisc, for intra-articular injection, per dose |
The LCD has been updated to include these HCPCS codes. These codes replace the use of J7317, J7319, J7320 and J3590 (as applicable).
A copy of the updated Local Coverage Determination can be found at the following web address: https://www.cahabagba.com where you can click on your state for the information you need.